From the Journals

No added benefit of time-restricted eating in NAFLD


 

Eat less, exercise more

Although the study found no additional benefit from TRE, it’s still good advice to skip snacking in the evening, Dr. Ganjhu said in an interview. “No one snacks on anything healthy at night. I mean, who’s chewing on celery?” she added.

Eating late at night can trigger reflux, so “not eating anything for several hours before bed or better yet going for a walk after dinner to kickstart your metabolism is good advice,” Dr. Ganjhu said.

For obesity and fatty liver disease, it really comes down to diet and exercise, she noted.

“For all the money that is going into pharmaceuticals, the long and the short of it is you just have to eat less and work out more and manage all the other factors like diabetes, high blood pressure, and metabolic syndrome. But getting people to follow that is tough,” Dr. Ganjhu said.

The study was supported by grants from the National Key Research and Development Project, Joint Funds of the National Natural Science Foundation of China, and Key-Area Clinical Research Program of Southern Medical University. Dr. Wei and Dr. Ganjhu report no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Noninvasive liver test may help select asymptomatic candidates for heart failure tests
MDedge Internal Medicine
Can a nationwide liver paired donation program work?
MDedge Internal Medicine
Be aware of hepatic encephalopathy, dementia overlap in older patients with cirrhosis
MDedge Internal Medicine
Exercise training reduces liver fat in patients with NAFLD, even without weight loss
MDedge Internal Medicine
Intermittent fasting plus exercise a good option for fatty liver
MDedge Internal Medicine
Mortality increases substantially with fibrosis stage in NAFLD
MDedge Internal Medicine
Posttransplant NASH patients fare worse with older donor livers
MDedge Internal Medicine
CDC recommends screening all adults for hepatitis B
MDedge Internal Medicine
PNPLA3 genotype predicts cirrhosis in NAFLD
MDedge Internal Medicine
Semaglutide doesn’t improve fibrosis in NASH-related cirrhosis
MDedge Internal Medicine